Phase I study of O6-benzylguanine and temozolomide administered daily for 5 days to pediatric patients with solid tumors. (Q46761560)

From Wikidata
Jump to navigation Jump to search
scientific article published in October 2005
edit
Language Label Description Also known as
English
Phase I study of O6-benzylguanine and temozolomide administered daily for 5 days to pediatric patients with solid tumors.
scientific article published in October 2005

    Statements

    Phase I study of O6-benzylguanine and temozolomide administered daily for 5 days to pediatric patients with solid tumors (English)
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit